Value
5.4/10data confidence 33%| Component | Sub-score |
|---|---|
| P/S | 0.0 |
| Analyst target | 9.0 |
ENVX · Why this verdict
Why Enovix (ENVX) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.8/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
ENVX is a high-growth, pre-profitability company expanding revenue at 49% year-over-year with 61% headroom to the $11.40 analyst-derived target and a risk/reward of roughly 8.6-to-1 in your favor — but free cash flow is negative at -210% of revenue, the financial health score is 3 out of 9, and a confirmed death cross with 26% short interest make this a speculative setup that requires meaningful improvement in unit economics before it becomes actionable.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Revenue expanding at 49% year-over-year places the company among the fastest growers in coverage, and three of the four most recent quarters beat consensus before the most recent in-line result — a trajectory that supports the view that commercial adoption is accelerating. Growth breakdown | Revenue growth stays above 30% YoY for the next two quarters and earnings surprises remain at or above 0%. | →Stable |
| CounterHigh revenue growth for a pre-profitability company may reflect early-stage adoption that decelerates as the initial customer base saturates; the shift from three consecutive beats to the most recent in-line result may be a leading indicator of that deceleration. | ||
Free cash flow is negative at -210% of revenue — meaning the business consumes more than twice its revenue in cash — while the financial health score of 3 out of 9 signals broad balance sheet stress, making continued access to external capital a prerequisite for the growth story to remain intact. Quality breakdown | If unit economics improve, free cash flow turns positive for 2 consecutive quarters, demonstrating the business can fund its own operations. | →Stable |
| CounterPre-profitability, high-growth companies routinely run deeply negative free cash flow during the investment phase; if revenue scales rapidly enough, the burn rate per dollar of revenue may compress faster than the headline cash consumption figure suggests. | ||
A death cross is in force with the 200-day moving average declining at -8.8% over 30 days, and 26% short interest means any further weakness is likely to be amplified as momentum sellers and short-side pressure compound — the technical environment creates a hostile backdrop for new long positions. Engine gate (failed) | If the downtrend reverses, short interest falls below 15% and the stock closes above the 200-day moving average for 10 consecutive sessions, confirming a trend change. | →Stable |
| Counter26% short interest creates significant potential for a short squeeze if a positive catalyst — a commercial contract, improved unit economics, or a strategic partnership — emerges unexpectedly; the same elevated short position that amplifies downside also amplifies any upside surprise. | ||
Analyst consensus implies approximately 85% upside, and the technical price target of $11.40 offers 61% headroom from the current $7.08 — a risk/reward of roughly 8.6-to-1 — suggesting the market is pricing in a scenario of continued distress that analysts believe the growth trajectory can overcome. Sentiment breakdown | Stock closes within 20% of the $11.40 target within 12 months as revenue growth translates into improving unit economics. | →Stable |
| CounterWide analyst upside estimates on pre-profitability small-caps frequently reflect optimistic terminal assumptions that are revised sharply downward as burn rates persist; if cash consumption forces a dilutive equity raise, the per-share target may compress even as the business grows. | ||
Revenue expanding at 49% year-over-year places the company among the fastest growers in coverage, and three of the four most recent quarters beat consensus before the most recent in-line result — a trajectory that supports the view that commercial adoption is accelerating.
→StableGrowth breakdown
- Expectation
- Revenue growth stays above 30% YoY for the next two quarters and earnings surprises remain at or above 0%.
CounterHigh revenue growth for a pre-profitability company may reflect early-stage adoption that decelerates as the initial customer base saturates; the shift from three consecutive beats to the most recent in-line result may be a leading indicator of that deceleration.
Free cash flow is negative at -210% of revenue — meaning the business consumes more than twice its revenue in cash — while the financial health score of 3 out of 9 signals broad balance sheet stress, making continued access to external capital a prerequisite for the growth story to remain intact.
→StableQuality breakdown
- Expectation
- If unit economics improve, free cash flow turns positive for 2 consecutive quarters, demonstrating the business can fund its own operations.
CounterPre-profitability, high-growth companies routinely run deeply negative free cash flow during the investment phase; if revenue scales rapidly enough, the burn rate per dollar of revenue may compress faster than the headline cash consumption figure suggests.
A death cross is in force with the 200-day moving average declining at -8.8% over 30 days, and 26% short interest means any further weakness is likely to be amplified as momentum sellers and short-side pressure compound — the technical environment creates a hostile backdrop for new long positions.
→StableEngine gate (failed)
- Expectation
- If the downtrend reverses, short interest falls below 15% and the stock closes above the 200-day moving average for 10 consecutive sessions, confirming a trend change.
Counter26% short interest creates significant potential for a short squeeze if a positive catalyst — a commercial contract, improved unit economics, or a strategic partnership — emerges unexpectedly; the same elevated short position that amplifies downside also amplifies any upside surprise.
Analyst consensus implies approximately 85% upside, and the technical price target of $11.40 offers 61% headroom from the current $7.08 — a risk/reward of roughly 8.6-to-1 — suggesting the market is pricing in a scenario of continued distress that analysts believe the growth trajectory can overcome.
→StableSentiment breakdown
- Expectation
- Stock closes within 20% of the $11.40 target within 12 months as revenue growth translates into improving unit economics.
CounterWide analyst upside estimates on pre-profitability small-caps frequently reflect optimistic terminal assumptions that are revised sharply downward as burn rates persist; if cash consumption forces a dilutive equity raise, the per-share target may compress even as the business grows.
Per-dimension breakdown
Quality
1.6/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 0.3 |
| Net margin | 0.0 |
| Current ratio | 5.0 |
| FCF quality | 0.0 |
| Moat | 4.2 |
| Piotroski F | 3.3 |
- ▸Cash-burning: FCF -210% of revenue
- ▸No competitive moat
- ▸Weak Piotroski F-Score: 3/9
- ▸Quality concerns
Growth
10.0/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
- ▸Strong growth: 49% YoY
Momentum
1.2/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.0 |
| MACD | 0.9 |
| OBV | 1.0 |
| MA position | 1.0 |
| Volume | 0.0 |
- ▸Capitulation risk (RSI 27, below 200MA)
- ▸Volume distribution (falling OBV)
- ▸Below 200-MA, MA slope -6.9%/30d — confirmed downtrend
Sentiment
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 10.0 |
| erm sentiment | 4.4 |
- ▸Analyst upside: 118%
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
Peer rank
1.7/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 0.6 |
| quality rank | 0.0 |
| growth rank | 6.1 |
Technical
5.8/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 8.4 |
| support resistance | 9.7 |
| 52w position | 0.0 |
| gap | 5.0 |
Risk (lower is worse)
2.8/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 0.9 |
| days to cover | 3.9 |
| volatility | 0.0 |
| put call | 9.4 |
| implied vol | 0.0 |
| beta | 2.6 |
| debt equity | 2.8 |
- ▸High short interest justified: 26%
- ▸High IV: 103%
Catalyst
7.2/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 8.9 |
- ▸Strong earnings: 3B/0M
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (7)
- ASYMMETRY:6.0>=1.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:34d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- MOMENTUM:1.2<4.5
- DEATH_CROSS:HARD_BLOCK
Warning (0)
none
Reward-to-Risk
5.97
Upside
+89.5%
Downside
15.0%
Sizing output
AVOID
SetupFALLING_KNIFE — Death cross, below all MAs, RSI 27, MACD bearish
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — Beta 2.21>1.3, MCap $1.3B<$5B
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Growth at 10.0 could not lift the engine output above the verdict floor. Failed gate signal: MOMENTUM:1.2<4.5.
The strongest dimensions are Growth at 10.0, Catalyst at 7.2, and Sentiment at 6.5; the weakest are Momentum at 1.2, Quality at 1.6, and Peer rank at 1.7. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of 5.97 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Revenue expanding at 49% year-over-year places the company among the fastest growers in coverage, and three of the four most recent quarters beat consensus before the most recent in-line result — a trajectory that supports the view that commercial adoption is accelerating.
Trip ifRevenue growth falls below 25% YoY for 2 consecutive quarters.
- P2Free cash flow is negative at -210% of revenue — meaning the business consumes more than twice its revenue in cash — while the financial health score of 3 out of 9 signals broad balance sheet stress, making continued access to external capital a prerequisite for the growth story to remain intact.
Trip ifFree cash flow turns positive (FCF rises above 0% of revenue) for 2 consecutive quarters, demonstrating self-funding capability.
- P3A death cross is in force with the 200-day moving average declining at -8.8% over 30 days, and 26% short interest means any further weakness is likely to be amplified as momentum sellers and short-side pressure compound — the technical environment creates a hostile backdrop for new long positions.
Trip ifShort interest falls below 15% and the stock closes above the 200-day moving average for 10 consecutive sessions, confirming a sustained trend reversal.
- P4Analyst consensus implies approximately 85% upside, and the technical price target of $11.40 offers 61% headroom from the current $7.08 — a risk/reward of roughly 8.6-to-1 — suggesting the market is pricing in a scenario of continued distress that analysts believe the growth trajectory can overcome.
Trip ifAnalyst consensus price target is revised down more than 40% to below $5, reflecting deteriorating confidence in the commercial ramp trajectory.